COVID-19 (Coronavirus) Update: Vaccine Updates | COVID-19 Information | Visitor Guidelines

Phase 1 Safety Study of Descartes-11 in Patients with Relapsed Refractory Myeloma

Protocol No
CARTESIAN-DESCARTES-11-RRMM
Principal Investigator
Binod Dhakal
Phase
I
Summary
To evaluate the safety of an investigational cell-based therapy called Descartes-11. The study will explore where Descartes-11 provides any benefit in subjects with Multiple Myeloma.
Description
Descartes-11 in relapse/refractory MM
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL